In particular, inhibition of IL-9 has shown promising results in reducing allergic inflammation and mucus hypersecretion in mice and in clinical studies an IL-9 blocking antibody has been shown to reduce exercise-induced asthma [18]. Here, IL9 is linked to asthma.